These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8037585)
21. Amplification of oncogenes in lung carcinoma grafted in nude mice. Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771 [TBL] [Abstract][Full Text] [Related]
22. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447 [TBL] [Abstract][Full Text] [Related]
23. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
24. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887 [TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
26. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines. van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061 [TBL] [Abstract][Full Text] [Related]
27. [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy]. Reyt E; Lavieille JP; Brambilla E; Barra Y; Riva C Ann Otolaryngol Chir Cervicofac; 1993; 110(6):310-5. PubMed ID: 8210089 [TBL] [Abstract][Full Text] [Related]
28. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types. Prins J; De Vries EG; Mulder NH Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508 [TBL] [Abstract][Full Text] [Related]
29. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas. Yokoyama Y; Sagara M; Sato S; Saito Y Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981 [TBL] [Abstract][Full Text] [Related]
30. Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell line. Köhler G; Veelken H; Rosenthal F; Mackensen A; Lindemann A; Schaefer HE; Lahn M Anticancer Res; 1997; 17(5A):3225-31. PubMed ID: 9413152 [TBL] [Abstract][Full Text] [Related]
31. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. Gugger M; Burckhardt E; Kappeler A; Hirsiger H; Laissue JA; Mazzucchelli L J Pathol; 2002 Apr; 196(4):408-15. PubMed ID: 11920736 [TBL] [Abstract][Full Text] [Related]
32. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes. Pechoux C; Chardonnet Y; Chignol MC; Noël P Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818 [TBL] [Abstract][Full Text] [Related]
33. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Kalemkerian GP; Jasti RK; Celano P; Nelkin BD; Mabry M Cell Growth Differ; 1994 Jan; 5(1):55-60. PubMed ID: 8123593 [TBL] [Abstract][Full Text] [Related]
34. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer. Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535 [TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma]. Zhao P; Hou N; Shao Y; Li XH Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109 [TBL] [Abstract][Full Text] [Related]
36. [Small cell carcinoma and carcinoids of the lung: morphology of apoptosis and expression of biomolecular markers of tumor growth]. Pal'tsev MA; Demura SA; Kogan EA; Jack G; Zende B Arkh Patol; 2000; 62(5):11-7. PubMed ID: 11076293 [TBL] [Abstract][Full Text] [Related]
37. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point. Gogusev J; Barbey S; Nezelof C Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523 [TBL] [Abstract][Full Text] [Related]
38. [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system]. Liedke M; Karnbach C; Kalinin V; Herbst B; Frilling A; Broelsch CE Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):255-9. PubMed ID: 14518255 [TBL] [Abstract][Full Text] [Related]
39. Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. Pelosi G; Fumagalli C; Trubia M; Sonzogni A; Rekhtman N; Maisonneuve P; Galetta D; Spaggiari L; Veronesi G; Scarpa A; Malpeli G; Viale G Anticancer Res; 2010 Oct; 30(10):4269-81. PubMed ID: 21036752 [TBL] [Abstract][Full Text] [Related]
40. [Immunohistochemistry of biomolecular markers of lung cancer]. Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]